Chinese officials are reportedly considering exempting certain essential US imports from retaliatory tariffs. Michael Hart, president of the American Chamber of Commerce in China, stated that Chinese authorities have been gathering input from businesses to identify critical supply chain components affected by the tariffs. Lifesaving drugs and healthcare products are among the sectors under review. The move comes amid escalating trade tensions, with President Trump recently increasing tariffs on Chinese goods. Market reactions in Asia and Europe suggest optimism that trade disputes may ease.
— new from The New York Times
